Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non–germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Gr

Authors

Shuchao Qin (ORCID: https://orcid.org/0000-0002-7708-5183)
Hanning Tang
Lei Fan (ORCID: https://orcid.org/0000-0002-9368-4987)
Wenyu Shi (ORCID: https://orcid.org/0000-0002-2371-3332)
Wei Xu (ORCID: https://orcid.org/0000-0003-4208-7477)
Huayuan Zhu (ORCID: https://orcid.org/0000-0003-3073-6345)
Run Zhang (ORCID: https://orcid.org/0000-0002-0943-824X)
Yi Xia
Bing-Zong Li (ORCID: https://orcid.org/0000-0002-2732-9354)
Yi Miao (ORCID: https://orcid.org/0000-0003-2542-8663)
Jianyong Li (ORCID: https://orcid.org/0000-0002-9931-4055)
Siqi Qian
Xiaoyan Xie (ORCID: https://orcid.org/0000-0001-8391-6599)
Lei Cao (ORCID: https://orcid.org/0000-0002-1464-4865)
Hui Jin (ORCID: https://orcid.org/0000-0003-0297-3052)
Yeqin Sha (ORCID: https://orcid.org/0000-0002-7726-1749)

Institutions

Nantong University (CN)
Soochow University (CN)
Affiliated Hospital of Nantong University (CN)
Second Affiliated Hospital of Soochow University (CN)
Jiangsu Cancer Hospital (CN)
Northern Jiangsu People's Hospital (CN)
Jiangsu Province Hospital (CN)
Nanjing Medical University (CN)

Publication Details

Journal: BMC Medicine
Published: 2025-10-24
DOI: https://doi.org/10.1186/s12916-025-04418-y
Primary Topic: Lymphoma Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
China Postdoctoral Science Foundation
Government of Jiangsu Province

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non–germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Gr

Shuchao Qin, Hanning Tang, Lei Fan, Wenyu Shi et al.

Oct 24, 2025

BMC Medicine

Lymphoma Diagnosis and Treatment

article

Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non–germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Gr

Shuchao Qin, Hanning Tang, Lei Fan, Wenyu Shi, Wei Xu, Huayuan Zhu, Run Zhang, Yi Xia, Bing-Zong Li, Yi Miao, Jianyong Li, Siqi Qian, Xiaoyan Xie, Lei Cao, Hui Jin, Yeqin Sha

October 24, 2025article en

Abstract

No abstract available for this paper.

BMC MedicineVol. 23(1)

Nantong University (CN), Soochow University (CN), Affiliated Hospital of Nantong University (CN), Second Affiliated Hospital of Soochow University (CN), Jiangsu Cancer Hospital (CN), Northern Jiangsu People's Hospital (CN), Jiangsu Province Hospital (CN), Nanjing Medical University (CN)

National Natural Science Foundation of China, China Postdoctoral Science Foundation, Government of Jiangsu Province

Openalex Percentile: Top 57%

Lymphoma Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.